Keywords: Procter Gamble Thorne deal, PG acquisition, L Catterton sale, wellness supplements M&A, personalized nutrition, consumer health acquisition

Key Highlights

  • The Procter & Gamble Company (NYSE:PG) agreed to acquire supplement maker Thorne HealthTech from Private Equity firm L Catterton for USD 3.8 billion.
  • P&G's chief executive publicly confirmed the agreement on August 4, 2026, describing it as expanding the company's presence in science-backed, personalized wellness products.
  • The deal adds Thorne's supplement and personalized health testing Business to P&G's existing health care portfolio.
  • Industry observers have characterized the Acquisition as a premium wellness play, reflecting continued consumer Demand for science-backed nutrition brands.

A Major Bet on Wellness

Procter & Gamble agreed to acquire Thorne, a supplement and personalized health testing company, from private equity owner L Catterton for USD 3.8 billion. P&G's chief executive confirmed the agreement publicly on August 4, 2026, framing it as a deliberate expansion into the fast-growing wellness and nutrition category, an area where consumer spending has continued to outpace many traditional personal care segments.

What Thorne Brings to P&G

Thorne makes science-backed dietary supplements and offers personalized health testing services, positioning it at the intersection of consumer nutrition and diagnostics. Folding Thorne into P&G's health care portfolio gives the consumer products giant a foothold in premium, direct-to-consumer wellness products that complement its existing over-the-counter health brands.

Timing and Expected Close

The transaction is expected to close later in 2026, subject to customary closing conditions. For L Catterton, the sale represents an exit from an Investment in the personalized nutrition space, while for P&G it marks one of its larger acquisitions in recent years as the company looks to diversify Revenue beyond its traditional household and personal care categories.

Where Things Stand

The USD 3.8 billion Thorne acquisition gives Procter & Gamble a direct entry point into the premium, science-backed supplements market, underscoring how large consumer products companies are increasingly acquiring specialized wellness brands rather than building similar capabilities from scratch.